Featured Story

Pfizer and its UK Supplier Fined by Competitions Authority for Overcharging The NHS

Pfizer and its UK Supplier Fined by Competitions Authority for Overcharging The NHS

Two pharmaceutical companies, Pfizer and Flynn Pharma, have been fined a total of almost £70 million for overcharging the NHS for epilepsy drug phenytoin sodium. The CMA said that for four years Pfizer charged prices between 780% and 1600% higher than previously, while Flynn charged its customers between 2300% and 2600% more than the prices previously charged by Pfizer.